Page last updated: 2024-09-03

blonanserin and Attention Deficit Disorder with Hyperactivity

blonanserin has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horiuchi, F; Kawabe, K; Ueno, SI	1

Other Studies

1 other study(ies) available for blonanserin and Attention Deficit Disorder with Hyperactivity

Article	Year
Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder. Psychiatry and clinical neurosciences, 2019, Volume: 73, Issue:12 Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Delayed-Action Preparations; Drug Therapy, Combination; Guanfacine; Humans; Male; Piperazines; Piperidines; Tourette Syndrome	2019

Article

Year

Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder.

Psychiatry and clinical neurosciences, 2019, Volume: 73, Issue:12

Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Delayed-Action Preparations; Drug Therapy, Combination; Guanfacine; Humans; Male; Piperazines; Piperidines; Tourette Syndrome

2019